Impact of HIV on the severity of influenza

References

• Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report. 2013. [cited 2016 Jan 26]. Available from: http://www.unaids.org/en/resources/campaigns/HowAIDSchangedeverything/factsheet.
   Google Scholar
• Crosby AW. Epidemic and peace, 1918. Part IV. Westport (CT): Greenwood Press; 1976.
   Google Scholar
• Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15–22.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Fact sheet on influenza nº 211. [cited 2015 Oct 15]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
   Google Scholar
• Shrestha S, Swerdlow D, Borse R, et al. Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). Clin Infect Dis. 2011;52(S1):S75–S82.
   PubMed Web of Science ®Google Scholar
• Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687–695.
   PubMed Web of Science ®Google Scholar
• Lessler J, Reich NG, Brookmeyer R, et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis. 2009;9(5):291–300.
   PubMed Web of Science ®Google Scholar
• Cori A, Valleron AJ, Carrat F, et al. Estimating influenza latency and infectious period durations using viral excretion data. Epidemics. 2012;4(3):132–138.
   PubMed Web of Science ®Google Scholar
• Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–785.
   PubMed Web of Science ®Google Scholar
• Treanor JJ. Influenza (including avian influenza and swine influenza). In: Bennett JE, Dolin R, Blaser MJ, editors. Principles and practice of infectious diseases. 8th ed. Philadelphia (PA): Elsevier Saunders; 2015. p. 2000.
   Google Scholar
• Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol. 2006;27(3):266–270.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002;50(9):1498–1503.
   PubMed Web of Science ®Google Scholar
• Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009;200(4):492–500.
   PubMed Web of Science ®Google Scholar
• Domínguez-Cherit G, Namendys-Silva SA, de la Torre A, et al. H1N1 Influenza pandemic of 2009 compared with other influenza pandemics: epidemiology, diagnosis, management, pulmonary complications, and outcomes. Curr Infect Dis Rep. 2010;12(3):204–210.
   PubMedGoogle Scholar
• Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl JMed. 2009;360(25):2605–2615.
   PubMed Web of Science ®Google Scholar
• Khandaker G, Dierig A, Rashid H, et al. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respi Viruses. 2011;5(3):148–156.
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258–264.
   PubMed Web of Science ®Google Scholar
• Robinson K, Kolls J, Alcorn J. The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol. 2015;34:59–67.
   PubMed Web of Science ®Google Scholar
• Johnstone J, Majumdar SR, Fox JD, et al. Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens and presentation. Chest. 2008;134(6):1141–1148.
   PubMed Web of Science ®Google Scholar
• Rello J, Pop-Vicas A. Clinical review: primary influenza viral pneumonia. Crit Care. 2009;13(6):235–241.
   PubMed Web of Science ®Google Scholar
• Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax. 1994;49:825–834.
   PubMed Web of Science ®Google Scholar
• Puchelle E, Zahm JM, Bertrand A. Influence of age on bronchial mucociliary transport. Scand J Respir Dis. 1979;60:307–313.
   PubMedGoogle Scholar
• McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19(3):571–582.
   PubMed Web of Science ®Google Scholar
• Boyd M, Clezy K, Lindley R, et al. Pandemic influenza: clinical issues. Med J Aust. 2006;185(10 Suppl):S44–S47.
   PubMed Web of Science ®Google Scholar
• Van der Sluijs KF, van der Poll T, Lutter R, et al. Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications. Crit Care. 2010;14(2):219–227.
   PubMed Web of Science ®Google Scholar
• Sharma S, Singh J, Hornstein D, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. J Am Med Assoc. 2009;302(17):1872–1879.
   Web of Science ®Google Scholar
• McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis. 2003;187(6):1000–1009.
   PubMed Web of Science ®Google Scholar
• Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis. 2005;192(2):249–257.
   PubMed Web of Science ®Google Scholar
• McAuley JL, Hornung F, Boyd KL, et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe. 2007;2(4):240–249.
   PubMed Web of Science ®Google Scholar
• King QO, Lei B, Harmsen AG. Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection. J Infect Dis. 2009;200(4):537–545.
   PubMed Web of Science ®Google Scholar
• Van der Sluijs KF, van Elden LJ, Nijhuis M, et al. Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol. 2006;290(1):L194–L949.
   PubMed Web of Science ®Google Scholar
• McNamee LA, Harmsen AG. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun. 2006;74(12):6707–6721.
   PubMed Web of Science ®Google Scholar
• Colamussi ML, White MR, Crouch E, et al. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood. 1999;93(7):2395–2403.
   PubMed Web of Science ®Google Scholar
• Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009;119(7):19101920.
   Web of Science ®Google Scholar
• Arredouani M, Yang Z, Ning Y, et al. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med. 2004;200(2):267–272.
   PubMed Web of Science ®Google Scholar
• Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med. 2008;205(2):323–329.
   PubMed Web of Science ®Google Scholar
• Morton SE, Mathai M, Byrd J, et al. Influenza A pneumonia with rhabdomyolysis. South Med J. 2001;94(1):67–69.
   PubMed Web of Science ®Google Scholar
• Chen H-P, Lin W-T, Tsai M-F, et al. Influenza A(H1N1) infection with rhabdomyolysis and acute renal failure-a case report. J Intern Med Taiwan. 2011;22:138–141.
   Google Scholar
• Ayala E, Tam J, Wehner JH, et al. Rhabdomyolysis associated with 2009 influenza A(H1N1). JAMA. 2009;302(17):1863–1864.
   PubMed Web of Science ®Google Scholar
• Takayanagi N, Tokunaga D, Kubota M, et al. Community-acquired pneumonia with rhabdomyolysis. Nihon Kokyuki Gakkai Zasshi. 2005;43(12):731–735.
   PubMedGoogle Scholar
• Perez-Padilla R, de la Rosa-Zamboni D, Ponce De Leon S, et al. INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361(7):680–689.
   PubMed Web of Science ®Google Scholar
• Ninove L, Daniel L, Gallou J, et al. Fatal case of Reye’s syndrome associated with H3N2 influenza virus infection and salicylate intake in a 12-year-old patient. Clin Microbiol Infect. 2011;17(1):95–97.
   PubMed Web of Science ®Google Scholar
• Wei CM, Chen HL, Lee PI, et al. Reye’s syndrome developing in an infant on treatment of Kawasaki syndrome. J Paediatr Child Health. 2005;41(5–6):303–304.
   PubMed Web of Science ®Google Scholar
• Reye RD, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera. A disease entity in childhood. Lancet. 1963;2(7311):749–752.
   PubMed Web of Science ®Google Scholar
• Gosalakkal JA, Kamoji V. Reye syndrome and Reye-like syndrome. Pediatr Neurol. 2008;39(3):198–200.
   PubMed Web of Science ®Google Scholar
• Schrör K. Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs. 2007;9(3):195–204.
   PubMedGoogle Scholar
• Sivadon-Tardy V, Orlikowski D, Porcher R, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2009;48(1):48–56.
   PubMed Web of Science ®Google Scholar
• Kwong JC, Vasa PP, Campitelli MA, et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013;13(9):769–776.
   PubMed Web of Science ®Google Scholar
• Gui L, Chen K, Zhang Y. Acute transverse myelitis following vaccination against H1N1 influenza: a case report. Int J Clin Exp Pathol. 2011;4(3):312–314.
   PubMed Web of Science ®Google Scholar
• Babamahmoodi F, Reza Davoodi A, Ghasemian R. Report of two rare complications of pandemic influenza A (H1N1). J Infect Dev Ctries. 2012;6(2):204–207.
   PubMed Web of Science ®Google Scholar
• Gadoth A. Influenza A/H1N1 encephalitis. Neurology. 2010;75(7):666–667.
   PubMed Web of Science ®Google Scholar
• Ukimura A, Satomi H, Ooi Y, et al. Myocarditis associated with influenza A H1N1pdm2009. Influenza Res Treat. 2012;2012:351979.
   PubMedGoogle Scholar
• Al-Amoodi M, Rao K, Rao S, et al. Fulminant myocarditis due to H1N1 influenza. Circ Heart Fail. 2010;3(3):e7–e9.
   PubMed Web of Science ®Google Scholar
• Rezkalla SH, Kloner RA. Influenza-related viral myocarditis. Wisc Med J. 2010;109(4):209–213.
   Google Scholar
• Hildebrandt H, Maassab HF, Willis PW. Influenza virus pericarditis: report of a case with isolation of Asian influenza virus from the pericardial fluid. Am J Dis Child. 1962;104(5):579–582.
   PubMedGoogle Scholar
• Jang JY, Chang HJ, Jang Y, et al. Constrictive pericarditis accompanied by swine-origin influenza A (H1N1) infection. Korean Circ J. 2010;40(10):539–542.
   PubMedGoogle Scholar
• de Meester A, Luwaert R, Chaudron JM. Symptomatic pericarditis after influenza vaccination: report of two cases. Chest. 2000;117(6):1803–1805.
   PubMed Web of Science ®Google Scholar
• Barnes M, Heywood A, Mahimbo A, et al. Acute myocardial infarction and influenza: a meta-analysis of case–control studies. Heart. 2015;101(21):1738–1747.
   PubMed Web of Science ®Google Scholar
• European Center for Prevention and Disease Control (ECDC). Guidance Priority Risk Groups for Influenza Vaccination, Stockholm. 2008 Aug. [cited 2015 Oct 26]. Available from: http://ecdc.europa.eu/en/publications/Publications/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf.
   Google Scholar
• Pasman L. The complication of coinfection. Yale J Biol Med. 2012;85(1):127–132.
   PubMedGoogle Scholar
• Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254(1):78–101.
   PubMed Web of Science ®Google Scholar
• Gazzola L, Tincati C, Bellistri GM, et al. The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps and therapeutic options. Clin Infect Dis. 2009;48(3):328–337.
   PubMed Web of Science ®Google Scholar
• Silvestri G. Embracing the complexity of HIV immunology. Immunol Rev. 2013;254(1):5–9.
   PubMed Web of Science ®Google Scholar
• Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev. 2013;26(1):2–18.
   PubMed Web of Science ®Google Scholar
• Xu H, Wang X, Veazey RS. Mucosal immunology of HIV infection. Immunol Rev. 2013;254(1):10–33.
   PubMed Web of Science ®Google Scholar
• Vandergeeten C, Fromentin R, DaFonseca S, et al. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood. 2013;121(21):4321–4329.
   PubMed Web of Science ®Google Scholar
• Nathan C. Points of control in inflammation. Nature. 2002;420(6917):846–852.
   PubMed Web of Science ®Google Scholar
• Kamat A, Misra V, Cassol E, et al. A plasma biomarker signature of immune activation in HIV-infected patients on antiretroviral therapy. Plos One. 2012;7(2):e30881–e30893.
   PubMed Web of Science ®Google Scholar
• De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12(10):1203–1207.
   PubMed Web of Science ®Google Scholar
• Lee N, Wong CK, Chan PKS, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. Plos One. 2011;6(10):e26050–e30860.
   PubMed Web of Science ®Google Scholar
• Sansonetti P, Sali M, Fabbiani M, et al. Immune response to influenza A(H1N1)v in HIV-infected patients. J Infect Dev Ctries. 2014;8(1):101–109.
   PubMed Web of Science ®Google Scholar
• Sheth AN, Althoff KN, Brooks JT. Influenza susceptibility, severity, and shedding in hiv-infected adults: a review of the literature. Clin Infect Dis. 2011;52(2):219–227.
   PubMed Web of Science ®Google Scholar
• Golden MP, Sajjad Z, Elgart L. Influenza and human immunodeficiency virus infection: absence of hiv progression after acute influenza infection. Clin Infect Dis. 2001;32(9):1366–1370.
   PubMed Web of Science ®Google Scholar
• Skiest DJ, Machala T. Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts. J Clin Virol. 2003;26(3):307–315.
   PubMed Web of Science ®Google Scholar
• Althoff K, Gange S, Sharp G, et al. Elevated 2009 H1N1 antibody titers in HIV-infected and uninfected women in the US: a sero-study, March 1 to September 30, 2009 [abstract]. 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco (CA). #807LB.
   Google Scholar
• Martínez E, Marcos M, Hoyo‐Ulloa I, et al. Influenza A H1N1 in HIV‐infected adults. HIV Med. 2011;12(4):236–245.
   PubMed Web of Science ®Google Scholar
• Bocelli L, Paisible AL, Barton B et al. Pandemic 2009 H1N1 influenza in HIV-infected patients, case control study. Infectious Diseases Society of America (IDSA) 49th Annual Meeting; 2011 Oct 20–23; Boston, Massachusetts. ( Poster abstract 440).
   Google Scholar
• Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. J Am Med Assoc. 2009;302(17):1896–1902.
   PubMed Web of Science ®Google Scholar
• Campos-Loza A, Soto-Ramirez L, Sierra-Madero J, et al. New swine origin influenza A in HIV-infected patients during the 2009 outbreak in Mexico City [abstract]. 17th Conference on Retroviruses and Oportunistic Infections; 2010; San Francisco (CA). #801.
   Google Scholar
• Riera M, Payeras A, Marcos M, et al. Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study. Aids. 2010;24(16):2461–2467.
   PubMed Web of Science ®Google Scholar
• Isais F, Lye D, Llorin R, et al. Pandemic (H1N1) 2009 influenza in HIV-infected adults: clinical features, severity, and outcome. J Infect Dis. 2010;61(5):437–440.
   Google Scholar
• Cohen C, Simonsen L, Sample J, et al. Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis. 2012;55(7):996–1003.
   PubMed Web of Science ®Google Scholar
• Cohen C, Moyes J, Tempia S, et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013;19(11):1766–1774.
   PubMed Web of Science ®Google Scholar
• López-Aldeguer J, Iribarren JA, Valencia E, et al. Outcomes in HIV-infected patients admitted due to pandemic influenza. Enferm Infecc Microbiol Clin. 2012;30(10):608–612.
   PubMed Web of Science ®Google Scholar
• Del Bianco RD, Santos MS, Ribeiro MC, et al. Clinical aspects of influenza A (H1N1) in HIV-infected individuals in São Paulo during the pandemic of 2009. Braz J Infect Dis. 2011;15(2):170–173.
   PubMed Web of Science ®Google Scholar
• Gonzalez E, Psevdos Jr, G, Tsveniashvili, L, et al. Clinical presentation of 2009 H1N1 influenza A disease in HIV-infected patients: experience from a large AIDS center in New York City. Infect Dis Clin Pract. 2011;19(5):340–342.
   Google Scholar
• Reyes TG, de la Rosa ZD, Ormsby C et al. Clinical features of subjects infected with HIV and H1N1 influenza virus [abstract]. 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco (CA). #803LB.
   Google Scholar
• World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2015-2016 northern hemisphere influenza season. Geneva: WHO; 2015 Feb. [cited 2015 Oct 23]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201502_recommendation.pdf?ua=1.
   Google Scholar
• Seasonal Influenza (Flu): HIV/AIDS and the Flu. 2015 Jan 8. [cited 2015 Oct 23]. Available from: http://www.cdc.gov/flu/protect/hiv-flu.htm.
   Google Scholar
• Anema A, Mills E, Montaner J, et al. Efficacy of influenza vaccination in HIV‐positive patients: a systematic review and meta‐analysis. HIV Med. 2008;9(1):57–61.
   PubMed Web of Science ®Google Scholar
• Beck CR, McKenzie BC, Hashim AB. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis. 2012;206(8):1250–1259.
   PubMed Web of Science ®Google Scholar
• Remschmidt C, Wichmann O, Harder T. Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety. Vaccine. 2014;32(43):5585–5592.
   PubMed Web of Science ®Google Scholar
• Malaspina A, Moir S, Orsega SM, et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis. 2005;191(9):1442–1450.
   PubMed Web of Science ®Google Scholar
• Grabowska K. Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect Dis. 2006;6:58–67.
   PubMed Web of Science ®Google Scholar
• Chiang H, Hung C, Lee C, et al. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care. 2011;15(4):R202–R212.
   PubMed Web of Science ®Google Scholar
• Cordero E, Pachón J, Rivero A, et al. Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Am J Respir Crit Care Med. 2000;162(6):2063–2068.
   PubMed Web of Science ®Google Scholar
• Lazarus R, Clutterbuck E, Yu LM, et al. A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults. Clin Infect Dis. 2011;52(6):736–742.
   PubMed Web of Science ®Google Scholar
• de Roux A, Schmöele-Thoma B, Siber GR, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis. 2008;46(7):1015–1023.
   PubMed Web of Science ®Google Scholar
• Falcó V, Jordano Q, Cruz MJ, et al. Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study. Vaccine. 2006;24(14):2567–2574.
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Ward JW, Hanson DL, et al. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001;32(5):794–800.
   PubMed Web of Science ®Google Scholar
• Recommended Immunizations for HIV Positive Adults. [cited 2015 Oct 19]. Available from: https://aidsinfo.nih.gov/contentfiles/recommended_immunizations_fs_en.pdf.
   Google Scholar
• Ho Y, Brandão AP, de Cunto B, et al. Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil. Vaccine. 2013;31(37):4047–4053.
   PubMed Web of Science ®Google Scholar
• French N, Gordon SB, Mwalukomo T, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med. 2010;362(9):812–822.
   PubMed Web of Science ®Google Scholar
• Bhorat AE, Madhi SA, Laudat F, et al. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination. Aids. 2015;29(11):1345–1354.
   PubMed Web of Science ®Google Scholar
• Pneumococcal Conjugate 13-Valent Vaccine (PCV13) for HIV-infected Individuals Questions and Answers for Immunization Providers – April 2015. [cited 2015 Oct 19]. Available from: http://www.immunizebc.ca/sites/default/files/graphics/qa_pcv13_hiv_march_25ch_draft-2.pdf.
   Google Scholar
• Singh S, Barghoorn J, Bagdonas A, et al. Clinical benefits with oseltamivir in treating influenza in adult populations: results of a pooled and subgroup analysis. Clin Drug Investig. 2003;23(9):561–569.
   PubMed Web of Science ®Google Scholar
• Muthuri SG, Venkatesan S, et al. Effectiveness of neuraminidase inhibitors in reducing the mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395–404.
   PubMed Web of Science ®Google Scholar
• Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005;366(9492):1175–1181.
   PubMed Web of Science ®Google Scholar
• Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. J Am Med Assoc. 2006;295(8):891–894.
   PubMed Web of Science ®Google Scholar
• Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother. 2003;51(1):123–129.
   PubMed Web of Science ®Google Scholar
• Fry AM, Goswami D, Nahar K, et al. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. J Infect Dis. 2014;14(2):109–118.
   Web of Science ®Google Scholar
• Cooper CL. Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity. Curr Opin Infect Dis. 2012;25(1):26–35.
   PubMed Web of Science ®Google Scholar
• Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Surveill Summ. 2011;60(1):1–24.
   Google Scholar
• Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003–1032.
   PubMed Web of Science ®Google Scholar
• Canini L, Conway JM, Perelson AS, et al. Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study. PLoS Comput Biol. 2014;10(4):e1003568–e1003579.
   PubMed Web of Science ®Google Scholar
• Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicenter cohort study. Lancet Infect Dis. 2010;10(8):521–526.
   PubMed Web of Science ®Google Scholar
• Cordero E, Perez-Romero P, Moreno A, et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clin Microbiol Infect. 2012;18(1):67–73.
   PubMed Web of Science ®Google Scholar
• Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant Surg. 2010;10(1):18–25.
   PubMed Web of Science ®Google Scholar
• Viasus D, Pano-Pardo JR, Pachon J, et al. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A (H1N1) virus infection. Chest. 2011;140(4):1025–1032.
   PubMed Web of Science ®Google Scholar
• Louie JK, Yang S, Acosta M, et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1) pdm09. Clin Infect Dis. 2012;55(9):1198–1204.
   PubMed Web of Science ®Google Scholar
• Renaud C, Kuypers J, Englund JA. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1. J Clin Virol. 2011;52(2):70–78.
   PubMed Web of Science ®Google Scholar
• Baz M, Abed Y, Papenburg J, et al. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med. 2009;361(23):2296–2297.
   PubMed Web of Science ®Google Scholar
• Van Kampen JJA, Bielefeld‐Buss AJ, Ott A, et al. Case report: oseltamivir‐induced resistant pandemic influenza A (H1N1) virus infection in a patient with AIDS and Pneumocystis jirovecii pneumonia. J Med Virol. 2013;85(6):941–943.
   PubMed Web of Science ®Google Scholar
• Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 Influenza. N Engl J Med. 2010;362(1):88–89.
   PubMed Web of Science ®Google Scholar
• Enoki Y, Ishima Y, Tanaka R, et al. Pleiotropic effects of levofloxacin, fluoroquinolone antibiotics, against influenza virus-induced lung injury. Plos One. 2015;10(6):e0130248–e0130263.
   Web of Science ®Google Scholar
• Veziris N, Truffot C, Mainardi J, et al. Activity of carbapenems combined with clavulanate against murine tuberculosis. Antimicrob Agents Chemother. 2011;55(6):2597–2600.
   PubMed Web of Science ®Google Scholar
• Nguyen TD, Williams B, Trang E. Cefepime therapy and all-cause mortality. Clin Infect Dis. 2009;48(7):902–904.
   PubMed Web of Science ®Google Scholar
• Giamarellou H, Antoniadou A. Antipseudomonal antibiotics. Med Clin N Am. 2001;85(1):19–42.
   PubMed Web of Science ®Google Scholar